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INTRODUCTION
BK virus (BKV) is a human polyomavirus that establishes a lifelong, persistent infection of the urinary tract. The virus encodes two oncoproteins, the large T and small t antigens, that have been shown to cause cancer in animal models, and recently BKV DNA has been detected in various urinary tract tumors including tumors of the prostate. Among the spectrum of human cancers, prostate tumors have a relatively low frequency of mutations in the p53 and RB] genes, indicating that an outside agent such as a virus may be inactivating the function of their gene products. Both large T and small t antigens are capable of doing so. The aims of this proposal are to determine if BKV is indeed present in these tumors and, if so, whether these oncogenic proteins are expressed and function to deregulate cell growth control.
BODY
Over the course of this project we have made significant progress towards completing the tasks that we proposed. This work has resulted in one peer-reviewed publication in Oncogene. In addition, we have presented our work at national and international meetings, and it has been well-received. Finally, we have collected additional data since the publication that will be incorporated into future publications. We set out to discover whether BKV might be playing a role in prostate cancer. We believe that our results demonstrate that such a role is possible. While we have not proven causality, we are convinced that further experimentation is required. We have applied for funding from other sources to continue these studies.
Our progress is described below after the appropriate items from the approved Statement of Work. Please note that rather than reproducing figures from our manuscript in Oncogene in the body of this report, I have referred to them instead. All other data is supported by figures in the text. The manuscript is attached as an Appendix. Task 1. To examine prostate tumors and matched normal tissue for the presence of BKV sequences (months 1-30) * isolate DNA and RNA from microdissected normal and tumor tissue (months 1-6) * perform PCR analysis of DNA (months 3-18) • perform IS-PCR and ISH analysis of DNA (months 3-24) This task was delayed early on in the project because of the amount of time it took to develop specific reagents for examining the prostate samples. However, this effort was well worth it since the results we have obtained are clean and highly reproducible. We have clear evidence for the presence of BKV DNA in both normal ducts and in atrophic epithelium. This has been shown both by solution PCR and by in situ hybridization, both using probes that are highly specific and sensitive for BKV. These results are shown in Figures 2 and 4 of the Oncogene manuscript, and are also included in the summary (Table 1) .
As for normal prostate, it has been more difficult that we anticipated to obtain such tissue. However, our analysis of the normal prostate, as well as of prostate samples with BPH, indicates that T antigen is not expressed in epithelial cells in these samples. We are currently performing the ISH analysis of these samples.
-perform sequence analysis of DNA (months 6-24) The DNA sequence analysis is shown in Figure 3 of the manuscript. The analysis of the T antigen coding region (early region) proves that the virus we are detecting is BKV and not SV40 or JCV, which are highly homologous to BKV. In addition, the sequence analysis of the regulatory regions indicates that at least three different strains of virus are present in the samples. Indeed, since submitting this manuscript we have performed additional analyses which indicate the presence of at least one other strain in prostate tumors. Of interest is that we do not detect the archetype strain, which is the strain that is thought to remain latent in the urinary tract. Rather, we find strains that are associated with acute disease. Moreover, the fact that we find strains that we do not study in the laboratory argues that we have not inadvertently contaminated our samples with laboratory virus.
-perform RT-PCR and IS-RT-PCR analysis of RNA (months 12-30)
As we discussed in the individual years' reports, we have added immunohistochemical assays for T antigen to this task. All samples have been analyzed by this method and a fraction of the samples are positive for T antigen expression. Interestingly, while both normal and atrophic epithelia are positive for viral DNA, only the atrophic lesions express T antigen ( Figure 5 of the manuscript). Also of interest is the finding that the T antigen is cytoplasmic. This indicates that we are not detecting viral replication, which would require T antigen to be present in the nucleus. We have also stained for p53 protein and in the T antigen positive cells, the p53 co-localizes to the cytoplasm (Figure 6 and 7), indicating that its function has been compromised: as a transcription factor, it must be in the nucleus to function. In those samples that are T antigen negative, the p53 is nuclear.
Having obtained a good handle on the status and sequence of the viral DNA and protein, during the past year we turned our attention to the RNA. Again, we have taken our time to carefully determine the best conditions for isolation of the RNA and its amplification for sequencing. We initially have concentrated on the p53 gene since we would predict that it would not be mutant in the BKV-positive cells. This is because the presence of T antigen is equivalent to mutations due to its inactivation of the p53 protein. Using laser capture microdissection, we have examined exons 5-9 of the p53 gene, the exons in which almost all tumor mutations are found, in both T antigen-positive atrophic epithelium and in T antigen-negative tumor cells. We have not yet detected any mutations in the T antigen-positive cells, whereas in a fraction of the tumor samples, we can find p53 mutations. We have analyzed about half a dozen pairs of samples to date, and are continuing this analysis. Some of the p53 sequence analysis is summarized in the following The captured cells from Samples 1-3 were T antigen-positive, cytoplasmic p53;
those from Sample 4 were T antigen-negative, nuclear p53. See Das, et al. for details (Appendix). Task 2. To determine how alterations in viral sequences in tumors affect the replication and transformation properties of the virus (months 9-36)
• construct genomic viral clones containing patient-derived sequences (months 9-24) • determine the ability of these clones to replicate in permissive host cells (months 12-36) * construct early region expression vectors containing patient-derived sequences (months 9-24) -determine the ability of these clones to interfere with normal growth control pathways involving pRb and p53 (months 18-36) We have begun to clone the regulatory regions from the patient derived materials. We have also developed an in vitro cell culture system, using primary renal proximal tubule epithelial cells, to study BKV replication in its natural host cell (Virology manuscript by Low, et al., see Appendix) . While this was not originally proposed in the application, we found it necessary to develop this system as we found other cell lines suboptimal for studying the viral life cycle. However, we have not been able to commence the functional studies on replication and transformation.
KEY RESEARCH ACCOMPLISHMENTS
-detection of BKV in normal and atrophic prostatic epithelia -detection of BKV T antigen in atrophic cells -co-localization of p53 with T antigen in cells -sequence analysis of BKV isolates from prostate -development of in vitro system for assaying BKV replication in its natural host cell -analysis of p53 sequence demonstrates a correlation between presence of mutations and absence of BKV T antigen REPORTABLE OUTCOMES BK virus (BKV) is ubiquitous in the human population and availability of biomarkers for PCA, the basic molecular establishes a lifelong, subclinical persistent infection in the mechanisms regulating its development and progression urinary tract. When the immune system is compromised, it are still very poorly understood (Nupponen and can cause severe disease in the kidney and bladder.
Visakorpi, 1999; Jiang et al., 2001; Kuefer et al., 2002 ; Detection of BKV sequences in urinary tract neoplasms Varambally et al., 2002; , has led to the postulate that this virus may induce human 2002). Recognition of the precursor lesions of PCA has oncogenesis through the function of its large tumor become a primary focus in recent years. High-grade antigen (TAg). In this study, examination of prostate prostate intraepithelial neoplasm (HGPIN), charactertumor tissue sections using in situ hybridization shows the ized by proliferation of epithelial cells in ducts and acini presence of BKV sequences in atrophic epithelium. (Bostwick and Brawer, 1987) , has been reported to be Solution polymerase chain reaction on DNA extracted the most likely precursor lesion for PCA in the US from the tissues and sequence analysis of the products (Myers et al., 1994; Bostwick, 1995 ; reviewed in reveal the presence of BKV regulatory and early region Gonzalgo and Isaacs, 2003) . Postatrophic hyperplasia sequences. In addition, immunohistochemical analysis (PAH), also referred to as proliferative inflammatory using monoclonal antibodies specific to TAg or p53 shows atrophy (PIA), is a proliferative atrophic lesion charthe expression of TAg in some of the samples and p53
acterized by a decrease of cytoplasmic mass as compared staining that can be correlated to TAg expression.
to benign glands. Atrophic epithelium in PAH has Although the normal cellular localization of TAg and recently been proposed to be a precursor to PIN and p53 is nuclear, double immunofluorescence labeling with PCA (De Marzo et al., 1999; Putzi and De Marzo, 2000; anti-p53 and TAg antibodies indicates colocalization of Shah et al., 2001; reviewed in De Marzo et al., 2003; p53 and TAg to the cytoplasm in the glandular epithelial . Several studies have identified focal cells of the sections. Although BKV DNA was found in areas of epithelial atrophy and have suggested their benign and atrophic lesions, TAg and p53 coexpression importance in prostatic carcinogenesis (Franks, 1954 ; was observed only in atrophic lesions. Gardner and Bennett, 1992; De Marzo et al., 2003; Oncogene (2004 ) 23, 7031-7046. doi:10.1038 /sj.onc.1207920 Nelson et al., 2003 . It has also been reported that Published online 19 July 2004 atrophy of prostatic glands is common in middle-aged and elderly men (Gardner and Culberson, 1987; Keywords: polyomavirus BK; large T antigen; p53; McNeal, 1988 (Bookstein et al., 1990; Sarkar et al., neoplasia 1992; Melamed et al., 1997; reviewed in Abate-Shen and Shen, 2000) . Although the mutation rate of the p53 gene in PCA is also low, p53 inactivation has been implicated in PCA progression (Bookstein et al., 1993; Bauer et al., Introduction 1995; Brewster et al., 1999; Osman et al., 1999; reviewed in Abate-Shen and Shen, 2000) . These observations have Prostate cancer (PCA) is the second leading cause of led researchers to speculate that an infectious agent cancer deaths in older men in the US (Gonzalgo and might play a role in PCA (McNicol and Dodd, 1991; Isaacs, 2003; Jemal et al., 2003) . In spite of the Ibrahim et al., 1992; Rotola et al., 1992; Cuzik, 1995; Noda et al., 1998 (Gardner, 1973; eye, liver, Kaposi's sarcoma, and bone (reviewed in Padgett, 1981; D6rries et al., 1994) . It resides in the Imperiale, 2000 Imperiale, , 2001 Reploeg et al., 2001 ; Tognon kidneys in a latent or persistent state, but can be et al., 2003) . reactivated upon immunosuppression of the host and is
The BKV genome is divided into regulatory, early, associated with hemorrhagic cystitis and polyomavirus and late regions, and encodes five major proteins nephropathy (Arthur et al., 1986; Hiraoka et al., 1991; (Figure 1; Seif et al., 1979; Frisque et al., 1984; Pipas, Pappo et al., 1996; Randhawa et al., 1999; Li et al., 1992) . (Nakashatri et al., 1988; studies are BKV specific and do not crossreact with JCV 1989 JCV , 1990 Kang and Folk, 1992; Simmons, 1995; Staib or SV40 . Using immunohistochemistry, we also detected et Shivakumar and Das, 1996; the expression of TAg in the atrophic lesions. Moreover, 1996 Moreover, , 1998a . TAg also regulates viral DNA replicaTAg expression could be correlated to p53 expression in tion and gene expression, and coregulates activated and this set of samples. Interestingly, double immunofluorbasal cellular transcription factors (Moens and Rekvig, escence labeling studies demonstrate that TAg and p53 2001). Small tumor antigen is also involved in transforcolocalize to the cytoplasm, but in the TAg-negative mation and viral and cellular DNA replication (Moens tumors, p53 is nuclear. and Rekvig, 2001 ). The late proteins, the capsid proteins VP1, VP2, and VP3, are also expressed from alternatively spliced mRNAs, after viral DNA replication. The regulatory region contains promoter/enhancer elements Results of the early and late genes and the origin of DNA replication (Imperiale, 2001; Reploeg et al., 2001; Before beginning to analyse resection specimens (patient and Steiger, 2003) . Different BKV strains show sequence samples) for the presence of BKV, we developed PCR variability in their regulatory regions. These strains and in situ hybridization (ISH) conditions and reagents derive from a common archetype strain, which infects that would have a high degree of specificity and the general population, due to deletions, duplications, sensitivity for BKV and not the related viruses, SV40 and rearrangements in the regulatory region (Rubinstein and JCV, which share about 69-75% sequence identity et Shah, 1996) . (Seif et al., 1979; Frisque et al., 1984; Pipas, 1992) . To The role of BKV in human neoplasia is not clear, due demonstrate this specificity, PCR amplification of to conflicting reports. In the urinary tract, Monini et al. plasmids containing SV40, JCV, and BKV sequences (1995) demonstrated the presence of BKV sequences by was performed (Figure 2a ). Using the early region polymerase chain reaction (PCR) in more than 50% of primers, BKVfor( 49 3 5 _490 7 ) and BKVrev( 4 3 58_438 2 ), a proboth normal and tumor tissues, including prostate. Viral duct of 577 base pair (bp) was observed with the BKV DNA could be detected in some tumors by Southern plasmid and no product was detected with SV40 or JCV. blotting, whereas PCR amplification was always re-A Southern blot of the products using the BKV2( 443 4-quired to find BKV in normal tissues, and further 4478) probe, which was also used for ISH studies, analysis revealed that viral sequences were integrated confirmed the sequence-specific amplification of the into the host chromosome in the six tumors that were BKV early region. In these reactions, we could detect as positive by Southern blotting. Sequence analysis of the little as 0.1 fg of BKV DNA (data not shown). Similarly, viral origin of replication discovered the presence of both the nested primers to the early region and the point mutations in one of the samples, defining it as a regulatory region were determined to be sequence new strain of BKV, designated as UROL. It has been specific, although the regulatory region assay is less shown in cell culture that similar mutations impair the sensitive (data not shown). A direct Southern blot of replication ability of the virus, leading to an increased BKV, JCV, and SV40 plasmids with the BKV2 probe transformation potential (Shinohara et al., 1993) .
confirms its specificity ( Figure 2b ). Hence, it was speculated that mutant genomes impaired
Having developed specific assays, we began analysing for replication might integrate into the host genome and patient samples. In all, 21 neoplastic adenocarcinoma eventually lead to cancer. Another report found high prostate tissue samples were selected for evaluation levels of BKV TAg expression in primary and metastatic (Table 1) . To test for the presence of BKV sequences, bladder carcinoma but not in non-neoplastic urothelium DNA extracted from formalin-fixed paraffin-embedded (Geetha et al., 2002) . In these studies, BKV TAg and samples was analysed by solution PCR using regulatory p53 were colocalized to the nuclei of tumor cells. Given and early region primers. Extreme care was taken to the results obtained with prostate and bladder carcinoavoid sample contamination: plasmid controls were not ma, along with kidney being the main site for BKV analysed with the tissue samples, different sets of persistence, tumors of the urinary tract are the most pipettors were used for the tissues and plasmids, and logical target sites for an etiological association with high-quality DNA grade water was used. The integrity BKV. Since p53 and Rbl mutations are not ubiquitous of the DNA was evaluated by amplification of the fin PCA, we reasoned that TAg might inactivate their globin gene. Nested amplification was employed for the function in a subset of tumors, similar to the role of the regulatory and early regions since it was possible that human papillomavirus E6 and E7 gene products in the copy number of the viral genome would be low. cervical carcinomas (Scheffner et al., 1991; Ibrahim First-round amplification was performed for 30 cycles et al., 1992; Iwasaka et al., 1993; Cuzik, 1995) . Hence, for the early region, after which a product was we were interested in screening prostatic carcinomas for detectable only by Southern blot (data not shown); BKV sequences and, if present, in determining if DNA after a second round (30 cycles) of amplification with could be correlated to protein expression. nested primers, enough product resulted for direct In this report, we demonstrate the presence of BKV detection by ethidium bromide staining. For the sequences in the epithelium of benign ducts and atrophic regulatory region, two rounds of 40 cycles were required lesions of neoplastic prostate tissues using in situ and to detect the PCR product due to the lower sensitivity of solution analysis. The primers and probe used in our this assay. Representative EtBr-stained agarose gels of Table 1 . A correct size early region product of 452 bp were positive each time they were assayed. The product was obtained in 12/16 of the samples every time they size for the regulatory region is variable due to possible were tested. Some samples, such as 4, 5, and 13, were rearrangements. Seven of the regulatory regions were 7035 DNA unable to be recovered while a monoclonal antibody to a 90 kDa tumorassociated glycoprotein expressed in mammary carcinomas gave nuclear staining in the breast samples (data confirmed to be BKV by sequence analysis (see below), not shown) (Colcher et al., 1981) . The IHC labeling Sample 9 was positive for the early region in three out of results reveal that 9/21 of the prostate tissue sections are six amplifications and was positive for the regulatory positive for TAg expression, that the TAg is mostly region.
cytoplasmic, and that it is expressed in atrophic lesions. To confirm the identity of the PCR products, they Next, we were interested in examining the prostate were sequenced (Figure 3) . Identical results were samples for the expression of p53, which becomes obtained from all the early region samples and the stabilized and inactivated on association with viral sequences were identical to the published BKV genomic oncoproteins including TAg (Lane and Crawford, sequence (Figure 3a) . The majority of the regulatory 1979; reviewed in Pipas and Levine, 2001). Anti-p53 regions showed identity or similarity to the TU strain staining results fall into three categories ( Figure 6 ): TAg (Sundsfjord et al., 1990) , while sample 9 appears to be and BKV DNA negative (nuclear p 53 ); p53 and TAg most similar to Dunlop (Figure 3b ). Interestingly, one positive (cytoplasmic/perinuclear localization of both sample (#5) appeared to have two different regulatory proteins in atrophic epithelium, panels D and E); and regions, one identical to TU and the other most similar TAg negative but BKV DNA positive (nuclear p53 in to wt-501 (Watanabe and Yoshiike, 1989). We were atrophic prostate gland; panels F and G). TAg-negative unable to obtain clean sequencing data from some of the BSC-1 cells stain weakly for p53, whereas the TAgregulatory region products. Products that were not able positive BSC-BKT show nuclear staining (panels A and to be sequenced directly were cloned into a plasmid B). Breast carcinoma tissue sections had robust p53 vector and sequenced, but these sequences did not staining (panel H) (Cattoretti et al., 1988; Moll et al., appear to be homologous to BKV. Thus, 44% of the 1992), and isotype-matched control antibodies did not samples contained regulatory regions that could be stain the prostate (panel C). We did not detect any p53 confirmed to be BKV. staining in stromal cells or normal epithelium. Since p53 We wished to use an independent means of detecting and TAg expression could be correlated, with what BKV DNA in these samples. We chose ISH using the appeared to be identical staining patterns, it was of BKV2 probe. Control experiments on BSC-I (TAginterest to examine p53 and TAg colocalization using negative) and BSC-BKT (TAg-positive) cells demondouble immunofluorescence labeling. The results show strate the specificity of the ISH conditions (Figure 4) . staining in the epithelial cells of the atrophic lesions, Panels C-G show ISH on a representative prostate with cytoplasmic colocalization of both proteins sample. This section, which was positive for BKV by (Figure 7 ). Sundsfjord et al., 1990; Negrini et ol., 1991; Monini et al., 1995) . Sample 5 yielded two PCR products shown as 5 and 5(L), the latter being the lower molecular weight product. Identical sequences are shown in hold Discussion (Flaegstad et al., 1999) , but these studies have been called into question by a report which demonstrated The experiments in this study were designed to that the antibody used by these authors is not specific investigate if BKV sequences are present in neoplastic for TAg . The antibody prostatic tissues. In addition, we wanted to examine we used is specific for TAg and does not cross react with viral oncoprotein expression and cellular p53 levels, and any cellular proteins (Harlow et at., 1981) . A report on determine if there was a correlation. Since BKV is bladder carcinoma found high expression of BKV TAg ubiquitous in the human population, there is speculation in primary or metastatic tumors but not in normal concerning the oncogenic potential of the virus (Imepithelium (Geetha et at., 2002) . In these studies, p53 periale, , 2001 Tognon et al., 2003) . The presence was colocalized with TAg to the nuclei of tumor cells, of BKV sequences in tumors has been reported in suggesting stabilization and inhibition of p513 function several studies (De Mattei et at., 1995; by TAg. This report by Geetha et al. (2002) is the first in 1995, 1996; Flaegstad et at., 1999; Jorgensen et al., 2000;  which BKV localization to tumor cells was demonGeetha et at., 2002). There are contradictory reports on strated, suggesting a causal role for BKV in oncogenesis. the presence of BKV DNA in urinary tract tumors:
We analysed PCA specimens for BKV because of Monini et at. (1995) detected BKV DNA using PCR in these previous reports along with the facts that the 3 1/52 samples, whereas V6lter et at. (1997) were unable urinary tract is the main site for BKV persistence and to find it (0/15). 
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MM Figure 3 Continued the possibility of false positives caused by contamination of DNA from the tissues. Moreover, our ISH results of reagents with laboratory viral sequences. Our confirm the presence of viral DNA in the samples. We controls without any DNA gave no PCR product even amplified the BKV early region in 94% and regulatory after both rounds of PCR amplification, indicating that region in 81% of the archival specimens, although we the positive signals were due to authentic amplification could only confirm the sequence of the regulatory region in 44% of the samples. Some samples were positive for DNA that can be correlated to TAg expression in the the early region but not the regulatory region. Since the same location, we are confident that we are detecting regulatory region has been shown to be prone to BKV TAg and not that of JCV or SV40, which are also rearrangement, it is possible that rearrangements led recognized by this antibody. We speculate that BKV to lack of recognition by the primers. In addition, the infects normal cells, induces the cells to PAH or PIA, regulatory region PCR assay is less sensitive than that and these eventually transform to tumor cells, since used for the early region. Our DNA sequencing data atrophic lesions are proposed to be precursors to indicate that the early regions are identical to the early HGPIN. It'is unclear why BKV might be lost upon region of BKV. We found a number of regulatory region progression to frank carcinoma, but it is possible that sequences, which were homologous to the TU, Dunlop, the reported proapoptotic effects of TAg, mediated and wt-501 strains. There is no obvious correlation through interactions with pRB family proteins, or between the regulatory region sequences and the chromosomal damaging effects of TAg, might be histopathology of the samples. Owing to the heteroincompatible with growth at that stage of carcinogenesis geneity of the cells in each sample, drawing such a (Theile and Grabowski, 1990; Tognon et al., 1996 ; correlation will require sequence analysis of DNA Trabanelli et al., 1998) . isolated from specific cells in each section rather than TAg expression could be correlated to elevated p53 from bulk DNA isolated from an entire section. We expression in the atrophic lesions and both proteins were have not determined if BKV is present episomally or is localized to the cytoplasm of the secretory cells. In the integrated into the genome. Our ISH studies detected absence of TAg, p53, where detectable, was nuclear. It is BKV sequences in 71% of the samples, and in all cases, unclear why these two proteins, particularly TAg, are the signal localized to the benign and proliferative not entering the nucleus, although this might be related atrophic lesions.
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to the function of the cellular protein, Parc, which has IHC analysis detected TAg expression in 43% of the previously been shown to sequester p53 in the cytoplasm samples. TAg was expressed in focal atrophic lesions (Nikolaev et al., 2003) . In the cytoplasm, TAg would not (simple atrophy) and in hyper-PIA, but was undetectbe able to support replication of the virus. We propose able in either benign or tumor areas of the tissues. Since that TAg drives proliferation of these cells through its our ISH and PCR analyses specifically detect BKV interactions with pRB and, by sequestering p53 in the 7042 cytoplasm, inhibits p53-mediated cell cycle arrest or benign, atrophic, or tumors by the pathologist. Paraffinapoptosis (Knippschild et al., 1996; Moll et al., 1996) . embedded breast tissue blocks were obtained from the breast Two groups have observed cytoplasmic BKV and SV40 tissue procurement core at the UMCCC. The Gleason scores TAg in neuroblastoma and thyroid tumors, respectively of the tissue specimens are listed in Table 1 . (Jorgensen et al., 2000; Vivaldi et al., 2003) . There is also precedence for the occurrence of cytoplasmic p53 in DNA extraction human tumors, including inflammatory breast cancer, Eight serial paraffin-embedded 5-pim tissue sections were used neuroblastoma, colon carcinoma, and malignant melafor DNA extraction. The sections were treated with 100% noma (Moll et al., 1992; Castresana et al., 1993; Bosari xylene for 2 x 10min at room temperature to remove the et Moll et al., 1995; Weiss et al., 1995) .
paraffin, washed with 100% ethanol, and dried in a Savant To our knowledge, there is no report of cytoplasmic p53
SpeedVac using medium heat. The EX-WAXT' extraction kit in PCA. Since the cytoplasmic staining of p53 is mostly (Serological Corp.) was used to extract DNA as indicated by in atrophic lesions, it is possible that others might not the manufacturer, with minor modification. DNA was precipitated from the tissues by incubation at -80'C for 2h have classified these lesions as cancer, however. Toand dissolved in 50jl of resuspension solution from the gether, these results suggest that a defect in p53 nuclear manufacturer. The DNA was subsequently stored at -20'C. A import could contribute to turnorigenesis.
2-1 d aliquot was used in the PCR assays. The extraction Our present findings support the hypothesis that process was performed in an area that was BKV free and care PIA lesions are precursors to HGPIN or PCA, as was taken to avoid crosscontamination of the samples by suggested previously. Distinct histopathological relafrequent changing of gloves between samples. tionships between cells found in PIA, HGPIN, and PCA have been reported, suggesting that PIA develops into
Oligoiicleotide primers and probes HGPIN or PCA (De Marzo et al., 1999) . PIA is
The sequence of oligonucleotide primers and probes used for frequently associated with acute and chronic inflammathese studies are shown in Figure 1 . The human fl-hemoglobin tory processes and is highly proliferative when comgene primers, KM38 and PCO3, amplify a 167 bp fragment pared with normal epithelium (Ruska et al., 1998) . (Vilchez et al., 2002) . Atrophic regions containing proliferative epithelial cells,
The first-round BKV early region PCR was performed using which are unable to differentiate into columnar secreprimers BKVfor(4935_4907) and BKVrev( 43 5 9_4382) to generate a tory cells, are usually located in the periphery of the 577 bp PCR product. The second, nested round was performed prostate, where PCAs most often occur (Nelson et al., using BKVnesfb( 4 895A871) and BKVnesrev( 4 443-4 4 67), which 2003). Although there is evidence to support the amplify a 452bp product. The first round BKV regulatory association between inflammation and PCA, the exact region PCR was performed using primers BKRRLT1( 4 0o 38 i) mechanismci till remaiens enfluive. W d sPecula thatexB and BKRRLT6(21_4O) (Monini et al., 1995) , yielding a 379bp mechanism still remains elusive. We speculate that BKV product. The nested, second round was performed using infects benign glands, transforms them to atrophic primers BRPI(s 2 -0i) and BRP2( 35 8-33 9), resulting in a 276bp lesions through TAg expression, and this ultimately product if there is no rearrangement of the regulatory region. leads to HGPIN and cancer.
The BKV early region oligonucleotide probe for ISH and The results in this report are in agreement with an Southern blotting, BKV2( 443 4-478), was 45 bases, and is earlier report of the presence of BKV DNA in prostate modified from a previous report (Bersagel et al., 1992) . A tumors (Monini et al., 1995) . Our data extend this scrambled probe with the same length and G+C content was finding by demonstrating expression of TAg to atrophic used as a control in the ISH studies. The sequence of the lesions in the tumors, where it colocalizes with p53. The scrambled probe is: 5'TGTTGATGTAGGATATGCGTCTG presence of the BKV genome and, more importantly, TTCTTCTTACACCGTGACACAA3Y. expression of its early protein TAg, is suggestive of a role in the development of PCA. These observations Plasmids emphasize the need for rigorous and more detailed
The plasmids used to determine the specificity of the PCR and investigations of the association of this virus with PCA probe were pBK-GEM, containing the BKV early region and the elucidation of pathways that may be regulated ; pJCV, containing the complete JCV by BKV.
genome, strain Madl (ATCC #45027); and pJYM, containing the complete SV40 genome, strain 776 (Lusky and Botchan, 1981) .
Materials and methods
PCR amplification
Human tissue specimens Extracted DNA was amplified using Titanium T " Taq DNA polymerase (Clontech) in a ThermoHybaid thermocycler Paraffin-embedded adenocarcinoma prostate resection speci-(Px2). All reactions were performed in a final volume of mens from radical prostatectomies, staged using standard 100l,1 containing 200nM each primer, 200pM dNTPs, 2y1 TNM (primary tumor, regional nodes, metastasis staging) template, and 1 U polymerase in 0.5 x buffer (20mM Tricinecriteria, were obtained from the Tissue Procurement Core at KOH, pH 8.0, 8 mM KCI, 1.75 mM MgCI 2 , and 1.87 pg/ml the University of Michigan Comprehensive Cancer Center bovine serum albumin (BSA)). The quality of the DNA was (UMCCC). One section from each of the tissue specimens was first ascertained by PCR (45 cycles) with the fl-globin primers. stained with hematoxylin and eosin to confirm diagnosis. The
The program used for fl-globin amplification consisted of samples were a mixture of three different histological types, initial denaturation at 94°C for 5 min followed by denaturation benign, atrophic, and tumor. Each case was evaluated for at 94°C for 30 s, annealing at 43°C for 30 s, and elongation at BKV and prostate cancer D Das et at 7043 72°C for I min, followed by final elongation at 72°C for 7 min.
Cellfixation for in situ studies For early region amplification, two rounds of 30 cycles each Cells in Culture were fixed using a slightly modified published were used. The template for second-round amplification protocol (Berger, 1986) . BSC-I (African green monkey kidney consisted of 30 1p product from the first-round amplification, cells) and BSC-BKT cells were grown on sterilized charged The program consisted of initial denaturation for 5min at Silane prep"' slides (Sigma) in Dulbecco's modified Eagle's 94°C followed by denaturation at 94'C for 30s, annealing at medium (GIBCO), supplemented with 100U/ml penicillin, 4T'C for 30s, and elongation at 72°C for I min, followed by 100y•g/ml streptomycin, and 10% fetal bovine serum, at 37°C final elongation at 72°C for 7min. For regulatory region in a 5% CO 2 incubator, and fixed by 20mi incubation in 4% amplification, each reaction was increased to 40 cycles and ina ldehyde soluton (16% so obtain fron inec-1 x buffer was used. The program consisted of initial paraformaldehyde solution (16% stock obtained from Elecdenaturation for 5min at 94'C followed by denaturation at tron Microscopy Sciences) at room temperature. After 94°C for 30s, annealing for 30s, and elongation at 72'C for fixation, the cells were rinsed in phosphate-buffered saline I mm, followed by final elongation at 72'C for 7mm. The (PBS), first with 3 x PBS (5 min) and then 1 x PBS (3 x 2 min). 1anneing tollowedtbyreinal elongation at 72°C for7min.The
The slides were dehydrated using increasing concentrations of annealing temperature for primers BKRRLT 1/BKRRLT6 was etao(5,7,nd9%5mm acatrmtmpaue)ai 52°C and BRPI/BRP2 was 47°C. The negative control tube ethanol (50, 70, and 95t ; 5 min each at room temperature), air contained all components except DNA template. Plasmid dried, and stored at-80'C. DNA controls were not amplified at the same time as tissue samples, to avoid cross contamination.
In situ DNA hybridization (ISH)
ISH was performed using a modified protocol (Singer et al., 1986; Nuovo, 1996; Wiedorn et al., 1999) , with digoxigenin Southern blotting (DIG)-labeled 45 bp probes. The probes were labeled with A 9-dil aliquot of the PCR reaction, or plasmid DNA, was terminal transferase using the DIG oligonucleotide tailing kit electrophoresed on a 1.5% agarose gel in 1 x TAE buffer (Roche). Formalin-fixed paraffin-embedded sections (4liM), (40mM Tris acetate and lmM EDTA, pH 7.8), stained with mounted on AES charged slides, were deparaffinized by EtBr, and photographed before transfer. The probes were immersing in xylene solution (2 x 5min) and then rehydrated labeled with terminal transferase using the DIG oligonucleoby incubation with decreasing concentration of ethanol (95, 75, tide tailing kit (Roche). The gel was washed sequentially before and 50%; 1 min each). The sections were incubated in Tristransfer in 250mM HCI, 10 min; ddHO 5min; denaturation buffered saline (TBS; 0.1 M Tris-HCI, pH 7.4, and 0.15 M NaC1) solution (0.5 M NaOH and 1.5 M HCl), 2 x 15 min; ddH 2 0, for 10 min before being treated with proteinase K (4.5 pg/ml in 5 min; neutralization solution (0.5M Tris-HCI, pH 7.5 and TBS) at 37C for 25 min for permeabilization. The proteinase K 1.5 M NaCl), 2 x 15 min; and 20 x SSC (0.3 M NaCl and 0.03 M treatment was stopped by washing in TBS rigorously for sodium citrate, pH 7.03), 10min. The gel was transferred 10rmin, with a change of buffer after 5rmin. This was followed overnight to nylon membrane (Roche) in 20 x SSC using the by two 10 min washes, first with ddH 2 O then with ethanol, and capillary method. The membrane was washed for 2 x 15 min in air-drying. For hybridization, the sections were prehybridized 2 x SSC before baking at 1 0°C for 30 min to fix the DNA to in 10% formamide, 10% dextran sulfate, and 2 x SSC for the membrane, followed by incubation in prehybridization 15min at 45°C. The probe (100pmol/ml) was added to the buffer (DIG Easy Hyb buffer; Roche) containing 0.1 mg/ml prehybridization mixture and denatured for 10min at 92°C PolyA for 30 min at 45°C. This was followed by hybridization after application on the sections, and hybridization was with denatured DIG-labeled probe (Ipmol/ml for PCR performed for 2h at 45°C in a humidified chamber. The products; lOpmol/ml for plasmid DNA) for 2h at 45°C in sections were then washed with 2 x SSC containing 0.2% BSA DIG Easy buffer containing 0.1 mg/ml PolyA. After hybridifraction V (Roche) at room temperature for 15 min followed by zation, the membrane was washed with 2 x SSC containing 0.1 x SSC containing 0.2% BSA fraction V for 15 min at 54°C. 0.1% sodium dodecyl sulfate (SDS) at room temperature for All subsequent incubations were at room temperature. The 2 x 15min followed by 0.1 x SSC containing 0.1% SDS for sections were blocked with BSA fraction V (50mg/ml) in TBS 30min at 55°C. All subsequent incubations were at room for 30min then incubated with alkaline phosphatase-conjutemperature. The membrane was incubated with I x maleic gated anti-DIG antibody (Roche) for 30min in a humidified acid (Roche) for 10min, blocked with blocking buffer (Roche) chamber. The anti-DIG antibody was diluted 1:65 in for 30min, and incubated with alkaline phosphatase-conjuconjugate dilution buffer (0.1M Tris-HCI pH 7.3, 0.15M gated anti-DIG antibody (Roche) for 30min. The anti-DIG MgCI 2 , 10mg/ml BSA fraction V). After two 10min washes antibody was diluted 1:7000 for ECL detection of PCR with TBS, the sections were incubated with BCIP/NBT products or 1:1000 for colorimetric detection of plasmid substrate, mounted with crystal mount (Biomeda Corp), and DNA. After four 15min washes, the membranes were visualized using an Olympus BX41 microscope. incubated with either BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium) substrate for colorimetric Immunohistochenistry (IHC) detection or CSPD substrate (Roche) for ECL detection, IHC was performed using a modified protocol (Brown et al., which was subsequently exposed to film. 1996; Shi et al., 2001) . Paraffin-embedded 4pM sections were deparaffinized and rehydrated as above. Nonenzymatic antigen Sequence analysis retrieval was performed by treatment with 0.01 M sodium citrate, pH 6.0, at 92°C for 50 min with a change of buffer after 20 min PCR products were separated by agarose-gel electrophoresis, The sections were cooled for 25 min, rinsed with PBS (3 x 5 min), extracted (Qiaquick gel extraction kit, Qiagen), and sent for treated with 3% H 2 0 2 for 10 min at room temperature to quench sequencing by the DNA Sequencing Core at the University of endogenous peroxidase, and rinsed in PBS for 2 x 5 min. The Michigan. Samples that did not yield interpretable results were sections were blocked with 1.5% horse serum (Vector Labs) in cloned into pGEM-T easy (Promega) and sequenced. The PBS for 45 min and incubated with primary antibody in PBS sequences were analysed using the ClustalW server alignment containing 1.5% horse serum for 45 min at room temperature in (NCBI Server). a humidified chamber. We tried five different antigen retrieval 7044 techniques and the results were identical. The anti-TAg antibody Sections were blocked with 2% horse serum in PBS for I h at was a mouse monoclonal antibody originally raised against SV40 room temperature, then incubated with anti-TAg antibody TAg (Harlow et al., 1981) , which crossreacts with BKV TAg
(1:200 dilution) for I h, followed by washing in PBS for (PAb416; 1 : 200 dilution in blocking buffer; isotype IgG 2 4,). The 4 x 5 min and incubation in Texas Red (TR)-conjugated antianti-p53 was a mouse monoclonal antibody, p53Ab-6 ((Vojtesek mouse IgG (1 : 150 dilution; Vector Labs) for l h in the dark. et a/., 1992) (Clone DO-I; 1:20 dilution in blocking buffer;
All samples were protected from light after this step. Next, isotype IgG2,,; Lab Vision)). The anti-androgen receptor was a sections were washed in PBS for 4 x 10rmin, incubated with mouse monoclonal antibody, ARAb-I ((Ruizeveld de Winter anti-p53 antibody (I : 20 dilution) for I h, and washed with et al., 1991) (Clone AR 441; 1:10 dilution in blocking buffer; PBS for 20rmin (4 x 5min). This was followed by incubation Lab Vision)), and the anti-breast carcinoma 90kDa glycoprotein with fluorescein (FITC)-conjugated anti-IgG (1 :150 dilution; was a mouse monoclonal antibody, ( (Colcher et al., 1981) (Clone Vector labs) for 1 h. Finally, slides were washed with PBS for B6.2; 1:50 dilution in blocking buffer; BioGenex). Purified 4 x 10rmin, mounted using DAPI (diaminopropyliodide) mouse IgG 2 , was used as a negative control (Sigma; 1:20 mounting media, coverslipped, and visualized using a fluoresdilution in blocking buffer). After incubation with primary cence microscope. For double labeling, additional controls antibody, sections were washed with PBS for 3 x 5min and were analysed in parallel. After the anti-TAg-and TRincubated with biotinylated secondary anti-mouse immunogloconjugated secondary antibody incubation, serial sections bulin antibody (ABC kit; Vector labs) at 1: 200 dilution in were also incubated with FITC-conjugated secondary antiblocking buffer for 451nin at room temperature. Sections were body in the absence of anti-p53 antibody to ensure there was washed with PBS for 3 x 10main and incubated with avidin/ no recognition by the FITC secondary antibody of the anti- Introduction recover essential non-waste blood products and return them to circulation, produce vitamin precursors, maintain The process by which BKV infects its host, completes blood pressure and blood volume, and communicate with an acute replication cycle, and then remains subclinical for the host immune system through the release of cytokines the lifetime of the host or becomes active upon immunowhen they sense infections or toxic molecules (Briggs et suppressive conditions is currently poorly understood. al., 2001; Daha and van Kooten, 2000) . A system has Therefore, we wanted to develop a model system in which been developed in which HPTE cells are able to maintain BKV could be studied in vitro under conditions similar to their differentiated state in vitro and function in a renal those it might encounter in vivo. Early studies on BKV assist device. This device was developed to perform the were performed using monkey-derived Vero cells, human nutrient recovery, blood pressure, and blood volume funcembryonic kidney cells, or human embryonic fibroblast tions for patients with failing kidneys (Humes et al., cells, which are not the normal target cells for the virus in 2002). The HPTE cells used in the renal assist device vivo (Maraldi et al., 1975; Seehafer et al., 1975) . We have are capable of being passaged in culture up to six times. chosen to characterize a BKV infection in human kidney Using these cells, we were able to observe viral protein epithelial cells due to the known ability of BKV to infect expression, DNA replication, and growth over the course tubular epithelium in humans (Randhawa et al., 1999) .
of infection of a known target cell type for BKV. We find Human proximal tubule epithelial cells (HPTE cells) are that BKV is capable of replicating efficiently and producan important part of the kidney nephron. These cells ing infectious virus particles within these cells. Interestingly, SV40 cannot infect these cells except in the presence of the GMI ganglioside. (Fig. IA) . As was the case for viral DNA, the VPI present at infection would be. We first examined expression of large T 0 h postinfection is probably from the input vinis. The first antigen (TAg) as a marker for early gene expression. The time that VPI was expressed de novo was at 36 h postinexpression of TAg and its interaction with p53 and the fection, when there was a marked increase in its steady-state retinoblastoma family of tumor suppressors are critical for a levels. High levels of VP1 expression were seen 12 h later. successful infection by polyomaviruses. We infected HPTE
The amount of VP I increased throughout the remainder of cells with BKV at an MOI of 5 fluorescence fomaing units the infection and was at its highest level when the time (FFU)/cell, isolated total protein over the course of 11 days, course ended at II days postinfection. and assayed TAg expression by immunoblotting (Fig. I A) .
When BKV infects a human kidney, it establishes a We first detected TAg expression between 12 and 24 subclinical infection unless the immune system has been h postinfection. Much higher levels of TAg expression were compromised. Under immunocompromised conditions or detected between 24 and 36 hi postinfection. The expression immunosuppression, usually resulting from organ or bone of TAg peaked at 7 days postinfection, and remained high marrow transplantation, pregnancy, or HIV infection, high throughout the rest of the time course, levels of BKV replication are observed in the kidneys and The next step in the BKV life cycle is replication of its urinary tract, which can lead to hemorrhagic cystitis and DNA. To assess this step, we isolated low molecular weight polyomavirus nephropathy (PVN) . Three DNA from HPTE cells infected with BKV and digested with of the morphologic hallmarks of PVN are intranuclear viral EcoRI to linearize the BKV genome. We analyzed the inclusions, focal necrosis of tubular cells, and cells rounding amount of viral DNA present by Southern blotting using up from the epithelial layer and extruding into the tubular the BKV genome as a probe. We detected the presence of lumen (Nickeleit et a] .. 1999). We examined the morphology low levels of viral DNA starting at 0 h postinfection (Fig. of BKV-infected HPTE cells. As early as 4 days postinfec-I B). Due to the low and constant level of viral DNA seen tion, we detected morphological characteristics in HPTE during the first 36 h of the infection, we believe that this is cells that are also commonly observed in PVN. The HPTE DNA from input virus. The first increase in viral DNA cells rounded up from the cell monolayer, likely due to cell occurred at 36 h postinfection, which is expected due to the death, and contained enlarged nuclei and what appeared to be onset of expression of TAg 12 h earlier. The level of viral inclusions (Fig. 2) . These characteristics were more evident DNA increased throughout the course of infection, peaking at 9 days postinfection. Thus, BKV apparently undergoes a at 9 days postinfection. Metabolic labeling experiments lytic infection in HPTE cells, producing morphologic using tritiated thymidine confimaed that viral DNA synthechanges similar to those seen in PVN. sis did not begin until 48 h postinfection (data not shown).
The key event to which all other viral events lead is After determining when early viral proteins were progeny virus production. We determined the viral yield expressed and viral DNA was replicated, we went on to over the course of an 11-day infection (Fig. 3) . At 24 establish when the major late viral protein VP1 was h postinfection, we detected the eclipse phase of infection, expressed. Total cellular protein was isolated from HPTE when fewer mature virions were present. We then observed humans (Butel and Lednicky, 1999 ; Garcea and Imperiale, days postinfection, concomitant with robust viral DNA and 2003) . SV40 is known to infect proximal tubule cells in the late protein synthesis. After this early peak, the release of monkey kidney, causing a disease similar to that seen in progeny virus remained relatively constant for the remainder humans (Sheffield et al., 1980) . Upon infecting HPTE cells of the infection.
and BSC-1 cells, an established line of monkey kidney cells, We were also interested in whether SV40 can infect with SV40 we expected similar morphologies to those seen HPTE cells. SV40 is the best studied of the polyomavirus in BKV-infected HPTE cells. However, at 11 days postinfamily and a close relative of BKV. An examination of fection, cytopathic effects were evident in SV4O-infected SV40 infection of human kidney cells is particularly inter-BSC-l cells, but not in HPTE cells. We looked for SV40 esting because of accumulating evidence that SV40 infects TAg as a marker of early protein expression. We detected high levels of TAg expression in BSC-1 cells, but none at all
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in HPTE cells, even at 13 days postinfection (Fig. 4A) It has been reported that the cellular receptor for SV40 is the major histocompatibility complex (MHC) class I molecule (Atwood and Norkin, 1989) . Immunoblotting of protein lysates from the HPTE cells revealed that these cells express this molecule at levels similar to human fibroblasts suscepDays Post-Infection tible to SV40 infection (data not shown). More recently, however, Tsai et al. (2003) have reported that the ganglio- infectivity by SV40. 1HPTE cells were incubated with either these cells is a critical first step to understanding how BKV GMl or GDla, reported as a receptor for mouse polyomacauses disease in the human host. vints (Py), and infected with SV40 or BKV (Tsai et al., We first observed expression of high levels of TAg at 36 2003). Immunoblots were used to detect the expression of h postinfection. This 36-h delay from infection to expresTAg. SV40 was able to infect HPTE cells preincubated with sion of abundant TAg corresponds to work by others who GM1, confirming that the GMI ganglioside is a receptor for observed that in human fibroblasts, nuclear uncoating of SV40 and indicating that the inability of SV40 to infect BKV occurs as late as between 24 and 30 h postinfection HPTE cells is due to a lack of this ganglioside (Fig. 4C) . (Maraldi el al., 1975) . We also observed high levels of VPl BKV was able to infect HPTE cells that had been preincuexpression and DNA replication beginning at 48 h postinbated with either GM1 or GDla, illustrating that GDla does fection, 12 h after TAg was strongly expressed. Two days not have an inhibitory effect on viral entry into these cells.
after the components of the mature virion were first synthesized, we observed a large peak in mature virion production.
Discussion
We do not have any indication that BKV can establish a latent or persistent infection in tubular epithelial cells in The experiments described in this paper define a system vitro. No cells survived the infection despite repeated in which BKV can be studied in vitro using a cell type that it attempts to passage them. One major difference between infects in vivo. While others have examined BKV infections HPTE cells infected in vitro and in vivo is the lack of an in cell culture, none of these previous studies have been immune system. Therefore, our system reproduces what performed at a molecular level in a cell type infected in vivo likely occurs during a BKV infection in an immunosup- (Flaegstad and Traavik, 1987; Maraldi et al., 1975) . We pressed individual. Because BKV is reactivated upon imhave shown that BKV causes morphological changes in munosuppression, it is clear that the body keeps viral vitro which are similar to those seen in BKV-induced replication in check without destroying the entire population nephropathy in vivo and that a productive infection occurs.
of infected cells. A component of the immune system While descriptive, the characterization of BKV infection of controlling BKV infection may be chemokines or cytokines.
For example, it has been demonstrated that cytokines are we believe that this system is an important first step towards capable of inhibiting promoter activity of other viruses:
better understanding how BKV interacts with the host. We IFN-cy inhibits murine CMV immediate early gene expresare left with at least two major areas of study to pursue. sion and IFN-,y inhibits gene expression of constructs under First, there are likely many cellular proteins and processes control of the human CMV or SV40 promoters (Gribaudo et that are influenced during infection. Second, we wish to al., 1995t Harms and Splitter. 1995; Qin el al., 1997) .
develop a model of BKV persistent infection and determine Further study is required to determine under which conwhat causes BKV to reactivate from its subclinical state. ditions BKV gene expression and replication might be repressed. The immune system may not be the only factor playing a role in activation of BKV firom its latent or Materials and methods persistent state. In studies of Py, it has been reported that mouse kidneys become permissive to lytic infection upon Cell culture cellular damage and subsequent tissue regeneration (Atencio et al., 1993) . It may be that a similar situation exists in the Human kidney proximal tubule epithelial cells, isolated transplant setting, in which BKV replication is stimulated from cadaveric tissue, were cultured as previously described due to either ischemia or kidney damage during handling. It (Humes et al., 2002) . The experiments described in this is also possible that a change in hormone levels or stress report were performed on cells isolated firom two separate within an individual could cause the reactivation of BKV, donors with no difference in the results. such as during pregnancy. PCR analysis of DNA isolated from uninfected HPTE cells revealed that these cells did not Viruseýs' harbor any detectable BKV sequences before infection (data not shown). Because it is known that BKV commonly BKV stocks were initially propagated in 293 cells from infects the proximal tubule in vivo, it may be slightly vinis obtained from the American Type Culture Collection surprising that we did not detect any viral sequences in (VR-837). Viral lysates were made through three cycles of our cell lines. It is possible that during an in vivo infection, fireezing the infected cells at -80 'C and thawing at 37 °C. only a few cells are infected, with this infection being kept Once we determined that HPTE cells could be lytically in check by the immune system and localized to certain infected, one subsequent passage was performed on HPTE areas of the kidney (Chesters et al., 1983) . Upon immunocells. The regulatory region of these stocks, as determined suppression, the infection may become lytic and infect a by sequencing of PCR products, was identical to the TU much larger population of kidney cells.
strain (Sundsfjord et al., 1990) . For the SV40 studies we We have also demonstrated that SV40 does not infect used strain 776. UPTE cells. Because SV40 infects tubular epithelial cells in monkeys, (Sheffield et al., 1980) we expected that our K'iral liters proximal tubule lines would be infected by SV40. The virus apparently does not enter HPTE cells without the addition of Viral titer was determined using a fluorescent focus the GMI ganglioside. It remains possible that in the absence assay, rather than hemagglutination inhibition, due to its of GMI, SV40 is internalized into HPTE cells through a ability to detect infectious virus. Seventy percent confluent different mechanism, but is unable to traffic to the nucleus HPTE cells in 12-well dishes were infected with 10-fold and begin lytic replication. Overexposures of our Southern dilutions of BKV for 4 days at 37 'C. The cells were fixed blots demonstrate the presence of input SV40 DNA in for 30 min using 70% ethanol/30% PBS (Liu and Atwood, HPTE infections in the absence of added gangliosides, but 2001) PAb416 (Hlarlow et al., 1981) followed by a fluoreswe are unable to determine if the virus has been internalized cein-conjugated anti-mouse antibody (Sigma) used to detect or remains on the cell surface. It is also possible that in TAg. Titei, measured in fluorescence forming units (FFU), humans SV40 infects a different type of cell within the was determined by counting five random fields. The titer of kidney, retaining its organ tropism, or infects a different SV40 was determined on BSC-I mnonolayers by the agar tissue entirely. Two groups have reported the detection of overlay method (Brockman et al., 1973) . SV40 sequences in diseased human kidneys (Butel et al., 1999; Li et al., 2002) , so it is possible that SV40 can Infections lytically infect kidney cells under some circumstances. Further study is required to determine why SV40 cannot Cells were grown in 6-well dishes to 70% confluence, infect proximal tubule epithelium and which human cells, if and infected with BKVor SV40 at an MOI of 5 FFU/cell. To any, might act as reservoirs for the virus in vivo.
stain with hematoxylin (Gill III formula), cells were fixed in We have developed a system in which we can study lytic 4% paraformaldehyde, washed with PBS, and rehydrated BKV replication in phenotypically normal human kidney with ethanol. For infections to which gangliosides were epithelial cells. Given the prevalence of BKV in the human added, cells were preincubated with either media, 3.2 gM population and its known associations with human disease, GM1, or 2.7 gM GDIa (gift of B. Tsai) for 18 h at 37 'C,
